Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor

In recent years, various approaches to the prodrug design on the basis of anti-HIV active nucleoside compounds used in the therapy are intensively investigated. In this paper, the principles of modifying this class of drugs by lipid substances allowing obtained conjugates to insert in natural lipid...

Full description

Bibliographic Details
Main Authors: N. S. Shastina, E. O. Baranova, L. N. Dyakova, D. V. Lonshakov, V. I. Shvets
Format: Article
Language:Russian
Published: MIREA - Russian Technological University 2011-04-01
Series:Тонкие химические технологии
Subjects:
Online Access:https://www.finechem-mirea.ru/jour/article/view/866
_version_ 1826565861707612160
author N. S. Shastina
E. O. Baranova
L. N. Dyakova
D. V. Lonshakov
V. I. Shvets
author_facet N. S. Shastina
E. O. Baranova
L. N. Dyakova
D. V. Lonshakov
V. I. Shvets
author_sort N. S. Shastina
collection DOAJ
description In recent years, various approaches to the prodrug design on the basis of anti-HIV active nucleoside compounds used in the therapy are intensively investigated. In this paper, the principles of modifying this class of drugs by lipid substances allowing obtained conjugates to insert in natural lipid transport and metabolic pathways that can increase nucleoside agents bioavailability are described. Literature data associated with the research of the pronucleotide approach serving the purpose of increasing nucleoside drugs therapeutical efficacy and reducing the side effects on the organism are reviewed. Experimental data obtained by the authors in course of research of synthetic routes and properties of the new lipid-modified anti-HIV nucleosides are also presented.
first_indexed 2024-04-10T03:31:09Z
format Article
id doaj.art-ac85836972ba4a5d858616a5573c3964
institution Directory Open Access Journal
issn 2410-6593
2686-7575
language Russian
last_indexed 2025-03-14T10:42:29Z
publishDate 2011-04-01
publisher MIREA - Russian Technological University
record_format Article
series Тонкие химические технологии
spelling doaj.art-ac85836972ba4a5d858616a5573c39642025-03-02T10:57:27ZrusMIREA - Russian Technological UniversityТонкие химические технологии2410-65932686-75752011-04-01627180860Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitorN. S. Shastina0E. O. Baranova1L. N. Dyakova2D. V. Lonshakov3V. I. Shvets4МИТХТ им. М.В. Ломоносова, 119571, Москва, пр-т Вернадского, д. 86МИТХТ им. М.В. Ломоносова, 119571, Москва, пр-т Вернадского, д. 86МИТХТ им. М.В. Ломоносова, 119571, Москва, пр-т Вернадского, д. 86МИТХТ им. М.В. Ломоносова, 119571, Москва, пр-т Вернадского, д. 86МИТХТ им. М.В. Ломоносова, 119571, Москва, пр-т Вернадского, д. 86In recent years, various approaches to the prodrug design on the basis of anti-HIV active nucleoside compounds used in the therapy are intensively investigated. In this paper, the principles of modifying this class of drugs by lipid substances allowing obtained conjugates to insert in natural lipid transport and metabolic pathways that can increase nucleoside agents bioavailability are described. Literature data associated with the research of the pronucleotide approach serving the purpose of increasing nucleoside drugs therapeutical efficacy and reducing the side effects on the organism are reviewed. Experimental data obtained by the authors in course of research of synthetic routes and properties of the new lipid-modified anti-HIV nucleosides are also presented.https://www.finechem-mirea.ru/jour/article/view/866anti-hiv-nucleosidesprodrugspseudo triglyceridesinositol containing phospholipidsbioavailability
spellingShingle N. S. Shastina
E. O. Baranova
L. N. Dyakova
D. V. Lonshakov
V. I. Shvets
Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
Тонкие химические технологии
anti-hiv-nucleosides
prodrugs
pseudo triglycerides
inositol containing phospholipids
bioavailability
title Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
title_full Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
title_fullStr Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
title_full_unstemmed Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
title_short Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
title_sort lipidic strategy for improving bioavailability of nucleoside hiv reverse transcriptase inhibitor
topic anti-hiv-nucleosides
prodrugs
pseudo triglycerides
inositol containing phospholipids
bioavailability
url https://www.finechem-mirea.ru/jour/article/view/866
work_keys_str_mv AT nsshastina lipidicstrategyforimprovingbioavailabilityofnucleosidehivreversetranscriptaseinhibitor
AT eobaranova lipidicstrategyforimprovingbioavailabilityofnucleosidehivreversetranscriptaseinhibitor
AT lndyakova lipidicstrategyforimprovingbioavailabilityofnucleosidehivreversetranscriptaseinhibitor
AT dvlonshakov lipidicstrategyforimprovingbioavailabilityofnucleosidehivreversetranscriptaseinhibitor
AT vishvets lipidicstrategyforimprovingbioavailabilityofnucleosidehivreversetranscriptaseinhibitor